PHAT
Phathom Pharmaceuticals, Inc. Common Stock
$13.64
0.00%
0.00
Notify me if price changes either direction
Buy PHAT stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.1B
Enterprise value
1.5B
Trailing PE
-2.572778763077
Forward PE
-126.56529
PEG Ratio
0.037319428211666
Enterprise to EBITDA
-6.836
Enterprise to revenue
9.882
Price to book MRQ
-2.3641303543652
Price to sales TTM
7.4997635
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
147.2M
EBITDA
-212776992
Diluted EPS TTM
-3.76
Total Cash (MRQ)
135.2M
Current ratio (MRQ)
2.231
Operating Cash Flow (TTM)
-225230000
PHAT trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
